Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

Website:www.sinobiopharm.com

(Stock code: 1177)

NOTIFICATION OF BOARD MEETING

The board of directors (the "Board") of Sino Biopharmaceutical Limited (the "Company") hereby announces that a meeting of the Board of the Company will be held on Tuesday, 23 March 2021 for the purposes of, inter alia, approving the publication of the annual results of the Company and its subsidiaries for the year ended 31 December 2020 and considering the recommendation of a final dividend, if any.

By order of the Board

Sino Biopharmaceutical Limited

Chan Oi Nin Derek Company Secretary

Hong Kong, 1 March 2021

As at the date of this announcement, the Board of the Company comprises nine executive directors, namely Ms. Tse, Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse, Eric S Y, Mr. Tse Hsin, Mr. Li Yi, Mr. Wang Shanchun, Mr. Tian Zhoushan and Ms. Li Mingqin and five independent non-executive directors, namely Mr. Lu Zhengfei, Mr. Li Dakui, Ms. Lu Hong, Mr. Zhang Lu Fu and Mr. Li Kwok Tung Donald.

Attachments

  • Original document
  • Permalink

Disclaimer

Sino Biopharmaceutical Limited published this content on 01 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 March 2021 08:35:11 UTC.